Author

Cloé Charpentier

MRI FOLLOW UP IN ACTIVE PERIANAL FISTULIZING CROHN’S DISEASE REFRACTORY TO ANTI-TUMOR NECROSIS FACTOR THERAPY RECEIVING USTEKINUMAB
MRI FOLLOW UP IN ACTIVE PERIANAL FISTULIZING CROHN’S DISEASE REFRACTORY TO ANTI-TUMOR NECROSIS FACTOR THERAPY RECEIVING USTEKINUMAB

Cloé Charpentier  et al.

SARCOPENIA IS AN INDEPENDENT PREDICTOR OF SURGERY AND HOSPITALIZATION IN STENOSING CROHN'S DISEASE
SARCOPENIA IS AN INDEPENDENT PREDICTOR OF SURGERY AND HOSPITALIZATION IN STENOSING CROHN'S DISEASE

Cloé Charpentier  et al.

Item 1 - 2 / 2
1